Showing results (11-20 of 201) with videos related to
Sort By:
Pageof 21
Pediatric Transplantation|December 10, 1999
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modalityR Champlin, I Khouri, S GiraltSeminars in Oncology|August 1, 1995
Treatment of chronic myelogenous leukemiaS Giralt, H Kantarjian, M TalpazActa Haematologica|January 1, 1996
T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantationR Champlin, S Giralt, J GajewskiSeminars in Hematology|April 1, 1995
The natural history of chronic myelogenous leukemia in the interferon eraS Giralt, H Kantarjian, M TalpazCytotherapy|May 6, 2010
Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC componentsS Rowley, B MacLeod, S Heimfeld, et al.Medical and Pediatric Oncology|May 8, 2000
Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumorsD Hawkins, T Barnett, W Bensinger, et al.Bone Marrow Transplantation|April 1, 1994
Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, K Longin, C D Buckner, et al.Bone Marrow Transplantation|May 10, 2016
Peer review in hematopoietic cell transplantation: are we doing our fair share?S Giralt, R Korngold, H M LazarusHaematologica|March 7, 2000
Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasiaA M Carella, S Giralt, S SlavinBone Marrow Transplantation|March 1, 2017
Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapyB Gyurkocza, H M Lazarus, S GiraltPageof 21